Literature DB >> 18930772

A novel concept in enteric coating: a double-coating system providing rapid drug release in the proximal small intestine.

Fang Liu1, Rosario Lizio, Christian Meier, Hans-Ulrich Petereit, Peter Blakey, Abdul W Basit.   

Abstract

A novel double-coating enteric system was developed to accelerate drug release in conditions resembling the upper small intestine. The system comprises an inner coat (partially neutralised EUDRAGIT L 30 D-55 and organic acid) and an outer coat (standard EUDRAGIT L 30 D-55). Prednisolone tablets were coated with double layer formulations with inner coats neutralised to pH 5.6 in the presence of 10% citric acid or adipic acid. A conventional single coating was also applied for comparison purposes. There was no drug release from the single coated or double-coated tablets in 0.1M HCl for 2 h using USP II apparatus. The lag times of drug release in subsequent pH 5.6 phosphate buffer (to resemble the pH condition of the proximal small intestine) were 102, 42 and 28 min for the single coated, adipic acid and citric acid double-coated tablets respectively. The lag time for release from the double-coated tablets was further reduced to 5 min when the inner coat was neutralised to pH 6.0 in the presence of 10% citric acid. The rapid drug release from the double-coating system was associated with faster polymer dissolution rates compared to the single coating. The novel double-coated system has the potential to provide rapid drug release in the proximal small intestine, overcoming the limitations of conventional enteric coatings.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18930772     DOI: 10.1016/j.jconrel.2008.09.083

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  10 in total

1.  Optimization of LY545694 tosylate controlled release tablets through pharmacoscintigraphy.

Authors:  Evelyn D Lobo; Mark D Argentine; David C Sperry; Alyson Connor; John McDermott; Lloyd Stevens; Ahmad Almaya
Journal:  Pharm Res       Date:  2012-06-14       Impact factor: 4.200

2.  Preparation and In Vitro-In Vivo Evaluation of Sustained-Release Matrix Pellets of Capsaicin to Enhance the Oral Bioavailability.

Authors:  Ya Zhang; Zhimin Huang; E Omari-Siaw; Shuang Lu; Yuan Zhu; Dongmei Jiang; Miaomiao Wang; Jiangnan Yu; Ximing Xu; Weiming Zhang
Journal:  AAPS PharmSciTech       Date:  2015-07-01       Impact factor: 3.246

3.  Interpolyelectrolyte complexes of Eudragit® EPO with hypromellose acetate succinate and Eudragit® EPO with hypromellose phthalate as potential carriers for oral controlled drug delivery.

Authors:  Balamurugan Jeganathan; Vijayalakshmi Prakya
Journal:  AAPS PharmSciTech       Date:  2015-01-16       Impact factor: 3.246

4.  Fabricating a Shell-Core Delayed Release Tablet Using Dual FDM 3D Printing for Patient-Centred Therapy.

Authors:  Tochukwu C Okwuosa; Beatriz C Pereira; Basel Arafat; Milena Cieszynska; Abdullah Isreb; Mohamed A Alhnan
Journal:  Pharm Res       Date:  2016-12-09       Impact factor: 4.200

5.  Assessment of the pharmaceutical quality of marketed enteric coated pantoprazole sodium sesquihydrate products.

Authors:  Haitham F Mostafa; Mohamed A Ibrahim; Gamal M Mahrous; Adel Sakr
Journal:  Saudi Pharm J       Date:  2011-01-22       Impact factor: 4.330

6.  Eudragit L/HPMCAS blend enteric-coated lansoprazole pellets: enhanced drug stability and oral bioavailability.

Authors:  Yu Fang; Guozheng Wang; Rong Zhang; Zhihua Liu; Zhenghua Liu; Xiaohui Wu; Deying Cao
Journal:  AAPS PharmSciTech       Date:  2014-03-05       Impact factor: 3.246

7.  Engineering of Naproxen Loaded Polymer Hybrid Enteric Microspheres for Modified Release Tablets: Development, Characterization, in silico Modelling and in vivo Evaluation.

Authors:  Hajra Afeera Hameed; Shahzeb Khan; Muhammad Shahid; Riaz Ullah; Ahmed Bari; Syed Saeed Ali; Zahid Hussain; Muhammad Sohail; Shafi Ullah Khan; Thet Thet Htar
Journal:  Drug Des Devel Ther       Date:  2020-01-07       Impact factor: 4.162

8.  In Vitro Evaluation of Enteric-Coated HPMC Capsules-Effect of Formulation Factors on Product Performance.

Authors:  Maoqi Fu; Johannes Andreas Blechar; Andreas Sauer; Jozef Al-Gousous; Peter Langguth
Journal:  Pharmaceutics       Date:  2020-07-23       Impact factor: 6.321

9.  A Novel Multilayer Natural Coating for Fed-State Gastric Protection.

Authors:  Rober Habashy; Mouhamad Khoder; Abdullah Isreb; Mohamed A Alhnan
Journal:  Pharmaceutics       Date:  2022-01-26       Impact factor: 6.321

10.  A Cyclodextrin-Based Controlled Release System in the Simulation of In Vitro Small Intestine.

Authors:  Danni Zheng; Liuxi Xia; Hangyan Ji; Zhengyu Jin; Yuxiang Bai
Journal:  Molecules       Date:  2020-03-07       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.